Search for: "Drug Process Licensing Associates LLC"
Results 101 - 120
of 121
Sort by Relevance
|
Sort by Date
27 Sep 2009, 2:30 pm
Turn-Key-Tech, LLC, 381 F.3d 1142, 1149 (Fed. [read post]
27 May 2009, 9:32 am
Foti now works at the law firm Kahn Gauthier Swick, LLC. [read post]
21 May 2009, 1:42 am
The five face possible suspension or revocation of their law licenses. [read post]
5 Dec 2008, 7:29 pm
Foti now works at the law firm Kahn Gauthier Swick, LLC. [read post]
1 Dec 2008, 4:14 pm
Drug and Device Law The Drug and Device Law blog is a joint project between two lawyers: Jim Beck and Mark Herrmann. [read post]
7 Nov 2008, 3:57 am
Political flurries and potential trade mark wars (Afro-IP) House arrest for DVD pirate (Afro-IP) Spain Government to publish ‘Manual of Best Practices in the Prosecution of Infringing Activities’ (Class 46) Ukraine Trade marks database to be accessible free of charge (Class 46) United Arab Emirates Limitations on trademark protection (International Law Office) United Kingdom Financing creative businesses (IP finance) UK patent… [read post]
13 Oct 2008, 12:12 pm
(IAM) Hong Kong 16 copyright piracy suspects identified during Operation Torpedo in Hong Kong (IP Dragon) India India unveils National Innovation Act (Spicy IP) National Innovation Act: part of trade secret law proposal dubbed 'absurd' (Managing Intellectual Property) Agriculture and Processed Food Products Exports Promotion Agency (APEDA) empowered to register Basmati as a GI (Spicy IP) CSIR looks to profit from patents stock (Philip Brooks' Patent… [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events… [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
11 Jul 2008, 4:30 am
: (IAM), (Patent Circle), India takes open source approach to drug discovery: (Patent Lens), India: Indian Bayh Dole Bill: (Spicy IP), (Spicy IP), (Does India need Bayh-Dole? [read post]
5 Jul 2008, 11:05 am
: (Intellectual Property Watch), Why compulsory licenses are bad: a look at the sausage making process: (Techdirt) More on ACTA: (LawFont.com) Global - Trade Marks / Domain Names / Brands Brand Finance 500: the annual report on the world’s most valuable brands: (IP finance), Gretchen Olive’s ‘10 steps to an effective domain name policy’: (IPwar’s), ICANN approves GNSO proposals imposing financial penalty on registrars who engage… [read post]
9 May 2008, 10:30 pm
: (Spicy IP), India: Merck vs Roche: towards differential pricing: (Spicy IP), India/Philippines: Access to drugs: The India/Philippines solution? [read post]
18 Apr 2008, 2:00 am
: (Spicy IP), India: OPPI recommends timeframe for pre-grant opposition: (Spicy IP), India: Jatropha patents (agri-biotech): (Spicy IP), India & US: Stem cell patents: (Spicy IP), Kenya: GSK presses Kenya to crack down on imports of fake medicines: (Afro-IP), Nigeria: Interview with Director General of NAFDAC - Cracking down on counterfeit drugs: (Afro-IP), EU: No link between parallel trade and reduction in R&D, says AG in Sot. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most… [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege or imaginary property? [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
9 Jan 2008, 12:15 am
(Savage & Associates PC v. [read post]
